Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer
about
Prognostic stratification of colorectal cancer patients: current perspectivesDecreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.Identification of prognostic inflammatory factors in colorectal liver metastases.Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.Impact of preoperative serum albumin on 30-day mortality following surgery for colorectal cancer: a population-based cohort study.A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer.CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer.Significance of Interleukin-6 in Papillary Thyroid Carcinoma.Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysisInterleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer.Perspectives in anaesthesia for cancer surgery.The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer.Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.Prognostic role of the combination of platelet count and neutrophil-lymphocyte ratio in patients with hypopharyngeal squamous cell carcinoma.The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.Investigation of JAKs/STAT-3 in lipopolysaccharide-induced intestinal epithelial cells.Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases.The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer.The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma.RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial
P2860
Q26823543-F387033E-702C-47BF-99CF-EA2CF9541728Q33905987-7B67AF84-1A44-430D-9252-7AD7944CF836Q34017917-9223B880-70D2-4CE6-A9C3-679F2E554041Q35198371-93D8F215-DEB9-4AAD-835B-D85068FF8354Q35611945-606EAF7C-458C-4251-9A9F-8DDFE62A1BE9Q35863154-6574F8A5-50B9-420D-AB59-F58976B94370Q36052673-0CC9E4E8-1128-4424-B4DF-7EC525DDF9D4Q36140448-623A7B47-9BDC-47E2-AC7A-26430C36F196Q36228663-033BB2D2-9558-4847-AF50-FFF0CEDD5F4EQ36502337-57695AF6-A46A-417F-847C-BFD4D51F8E14Q36731164-376475EE-D1BF-4FEC-8D1E-5FB6594D664AQ37063842-CAD85347-253C-4A64-9959-132EC7464F73Q37688887-D0AA2735-38AF-4948-9C97-19860BCE4665Q38146832-62AA960D-A303-47E0-8792-C2E25A2034EAQ38533166-C355ED7B-CD57-4E34-8B42-C696FA5F8FFFQ39390630-BED7E800-B0C3-4911-A8CE-D9BB02994343Q39884763-B3416763-777D-4611-9B08-711D62E7F781Q40509254-892F37D7-B930-47BD-BA2A-B09A4056E161Q41488328-FBD64567-7B55-455A-B0AD-B7DE9CFC74E4Q42773885-7EB8C664-FFCD-49EC-8643-7715A8827E05Q47140442-CC21C6F0-5E96-4577-AE63-16A457273FFBQ47590815-667A52A4-02DF-4CB8-8EAC-D9B39C198EC6Q49172009-66F5CC1B-5104-45ED-98F8-3D858CF237C3Q57170543-A00A6596-8656-4824-ACCD-79C4E2DB9850
P2860
Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating IL-6 concentration ...... esection for colorectal cancer
@en
Circulating IL-6 concentration ...... section for colorectal cancer.
@nl
type
label
Circulating IL-6 concentration ...... esection for colorectal cancer
@en
Circulating IL-6 concentration ...... section for colorectal cancer.
@nl
prefLabel
Circulating IL-6 concentration ...... esection for colorectal cancer
@en
Circulating IL-6 concentration ...... section for colorectal cancer.
@nl
P2093
P2860
P356
P1476
Circulating IL-6 concentration ...... esection for colorectal cancer
@en
P2093
C H Richards
C S D Roxburgh
G J K Guthrie
P G Horgan
P2860
P2888
P304
P356
10.1038/BJC.2013.291
P407
P577
2013-06-11T00:00:00Z